These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12234130)

  • 1. Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation.
    Spradling P; Nemtsova E; Aptekar T; Shulgina M; Rybka L; Wells C; Aquino G; Kluge H; Jakubowiak W; Binkin N; Kazeonny B
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):757-62. PubMed ID: 12234130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.
    Ruddy M; Balabanova Y; Graham C; Fedorin I; Malomanova N; Elisarova E; Kuznetznov S; Gusarova G; Zakharova S; Melentyev A; Krukova E; Golishevskaya V; Erokhin V; Dorozhkova I; Drobniewski F
    Thorax; 2005 Feb; 60(2):130-5. PubMed ID: 15681501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-resistant tuberculosis in Yangon, Myanmar.
    Phyu S; Lwin T; Ti T; Maung W; Mar WW; Shein SS; Grewal HM
    Scand J Infect Dis; 2005; 37(11-12):846-51. PubMed ID: 16308219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005.
    Mokaddas E; Ahmad S; Samir I
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):319-25. PubMed ID: 18284839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon.
    Araj GF; Saade M; Itani LY
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):63-7. PubMed ID: 16466039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia.
    Kherosheva T; Thorpe LE; Kiryanova E; Rybka L; Gerasichev V; Shulgina M; Nemtsova E; Aptekar T; Kluge H; Jakubowiak W; Grzemska M; Aquino G; Wells C; Kazionny B
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1045-51. PubMed ID: 14598963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia.
    Punga VV; Jakubowiak WM; Danilova ID; Somova TR; Volchenkov GV; Kazionnyy BY; Nemtsova ES; Kiryanova EV; Kourbatova EV
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1309-12. PubMed ID: 19793439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant tuberculosis among prisoners of three prisons in Bangkok and the vicinity.
    Tansuphasiri U; Pleumpanupat W; Pandii W; Rienthong S
    J Med Assoc Thai; 2003 Oct; 86(10):953-63. PubMed ID: 14650708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India.
    Swaminathan S; Paramasivan CN; Ponnuraja C; Iliayas S; Rajasekaran S; Narayanan PR
    Int J Tuberc Lung Dis; 2005 Aug; 9(8):896-900. PubMed ID: 16104637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
    Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
    Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
    Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of MDR-TB and polyresistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999.
    Kimerling ME; Slavuckij A; Chavers S; Peremtin GG; Tonkel T; Sirotkina O; Golubchikova V; Baddeley A
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):866-72. PubMed ID: 12971671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
    Sanders M; Van Deun A; Ntakirutimana D; Masabo JP; Rukundo J; Rigouts L; Fissette K; Portaelst F
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.